$1.78 Billion is the total value of Boxer Capital, LLC's 73 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 19.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | MIRATI THERAPEUTICS INC | $139,680,000 | +4.0% | 2,000,000 | 0.0% | 7.86% | -7.6% | |
| CYTK | CYTOKINETICS INC | $101,745,000 | +23.3% | 2,100,000 | 0.0% | 5.72% | +9.5% | |
| RXDX | PROMETHEUS BIOSCIENCES INC | $101,143,000 | +109.0% | 1,714,000 | 0.0% | 5.69% | +85.6% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $97,617,000 | +91.0% | 3,421,541 | +64.8% | 5.49% | +69.6% |
| APLS | APELLIS PHARMACEUTICALS INC | $89,043,000 | +51.0% | 1,303,700 | 0.0% | 5.01% | +34.1% | |
| RVMD | Buy | REVOLUTION MEDICINES INC | $78,570,000 | +15.7% | 3,984,264 | +14.4% | 4.42% | +2.7% |
| BGNE | BEIGENE LTDsponsored adr | $67,410,000 | -16.7% | 500,000 | 0.0% | 3.79% | -26.0% | |
| Sell | AMYLYX PHARMACEUTICALS INC | $58,665,000 | +38.5% | 2,084,000 | -5.3% | 3.30% | +22.9% | |
| TYRA BIOSCIENCES INC | $56,681,000 | +22.9% | 6,448,359 | 0.0% | 3.19% | +9.2% | ||
| RLAY | Sell | RELAY THERAPEUTICS INC | $48,523,000 | +8.5% | 2,169,132 | -18.7% | 2.73% | -3.6% |
| SAGE | SAGE THERAPEUTICS INC | $42,841,000 | +21.2% | 1,094,000 | 0.0% | 2.41% | +7.6% | |
| GOSS | Buy | GOSSAMER BIO INC | $42,792,000 | +107.6% | 3,571,928 | +45.1% | 2.41% | +84.4% |
| ITOS | ITEOS THERAPEUTICS INC | $41,035,000 | -7.5% | 2,154,058 | 0.0% | 2.31% | -17.9% | |
| MRUS | MERUS N V | $38,057,000 | -11.5% | 1,900,000 | 0.0% | 2.14% | -21.4% | |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $37,649,000 | -24.5% | 3,163,795 | -9.6% | 2.12% | -33.0% |
| RCUS | ARCUS BIOSCIENCES INC | $37,466,000 | +3.2% | 1,432,200 | 0.0% | 2.11% | -8.4% | |
| BLU | BELLUS HEALTH INC NEW | $33,792,000 | +14.3% | 3,200,000 | 0.0% | 1.90% | +1.4% | |
| ANAB | ANAPTYSBIO INC | $33,163,000 | +25.7% | 1,300,000 | 0.0% | 1.86% | +11.6% | |
| IDYA | IDEAYA BIOSCIENCES INC | $32,866,000 | +8.1% | 2,202,812 | 0.0% | 1.85% | -4.0% | |
| RETA | REATA PHARMACEUTICALS INCcl a | $31,136,000 | -17.3% | 1,239,000 | 0.0% | 1.75% | -26.6% | |
| New | VENTYX BIOSCIENCES INC | $29,674,000 | – | 850,000 | +100.0% | 1.67% | – | |
| VERU | New | VERU INC | $28,800,000 | – | 2,500,000 | +100.0% | 1.62% | – |
| AKRO | AKERO THERAPEUTICS INC | $28,312,000 | +260.3% | 831,495 | 0.0% | 1.59% | +219.7% | |
| TANGO THERAPEUTICS INC | $24,875,000 | -20.1% | 6,871,642 | 0.0% | 1.40% | -29.1% | ||
| FOLD | AMICUS THERAPEUTICS INC | $24,273,000 | -2.8% | 2,325,000 | 0.0% | 1.36% | -13.7% | |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $23,835,000 | +11.9% | 1,189,943 | 0.0% | 1.34% | -0.7% | |
| NUVALENT INC | $23,526,000 | +43.4% | 1,210,192 | 0.0% | 1.32% | +27.3% | ||
| RCKT | ROCKET PHARMACEUTICALS INC | $23,398,000 | +16.0% | 1,466,051 | 0.0% | 1.32% | +3.0% | |
| SRPT | SAREPTA THERAPEUTICS INC | $22,108,000 | +47.5% | 200,000 | 0.0% | 1.24% | +30.8% | |
| XENE | XENON PHARMACEUTICALS INC | $21,660,000 | +18.7% | 600,000 | 0.0% | 1.22% | +5.4% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $20,678,000 | +16.1% | 1,263,930 | 0.0% | 1.16% | +3.1% | |
| EXEL | New | EXELIXIS INC | $19,600,000 | – | 1,250,000 | +100.0% | 1.10% | – |
| PNT | POINT BIOPHARMA GLOBAL INC | $19,325,000 | +13.5% | 2,500,000 | 0.0% | 1.09% | +0.8% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $18,539,000 | -13.2% | 1,935,133 | 0.0% | 1.04% | -22.9% | |
| RNA | AVIDITY BIOSCIENCES INC | $18,311,000 | +12.4% | 1,121,327 | 0.0% | 1.03% | -0.2% | |
| PRTA | PROTHENA CORP PLC | $18,189,000 | +123.3% | 300,000 | 0.0% | 1.02% | +98.3% | |
| KNTE | Sell | KINNATE BIOPHARMA INC | $18,195,000 | -21.9% | 1,522,559 | -17.6% | 1.02% | -30.7% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $18,120,000 | -29.3% | 275,000 | -45.8% | 1.02% | -37.2% |
| NRIX | NURIX THERAPEUTICS INC | $15,960,000 | +2.8% | 1,224,892 | 0.0% | 0.90% | -8.6% | |
| CGEM | CULLINAN ONCOLOGY INC | $13,770,000 | 0.0% | 1,074,082 | 0.0% | 0.77% | -11.2% | |
| New | THIRD HARMONIC BIO INC | $10,821,000 | – | 570,417 | +100.0% | 0.61% | – | |
| ETNB | 89BIO INC | $8,106,000 | +79.8% | 1,400,000 | 0.0% | 0.46% | +59.4% | |
| FATE | Sell | FATE THERAPEUTICS INC | $7,844,000 | -36.7% | 350,000 | -30.0% | 0.44% | -43.8% |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $7,228,000 | +11.1% | 70,000 | 0.0% | 0.41% | -1.2% | |
| 2SEVENTY BIO INC | $6,691,000 | +10.2% | 459,836 | 0.0% | 0.38% | -2.1% | ||
| NGM | NGM BIOPHARMACEUTICALS INC | $6,540,000 | +2.0% | 500,000 | 0.0% | 0.37% | -9.4% | |
| MIST | Sell | MILESTONE PHARMACEUTICALS IN | $6,423,000 | -53.4% | 698,861 | -68.8% | 0.36% | -58.6% |
| ALT | New | ALTIMMUNE INC | $6,385,000 | – | 500,000 | +100.0% | 0.36% | – |
| COGT | COGENT BIOSCIENCES INC | $6,341,000 | +65.4% | 425,000 | 0.0% | 0.36% | +46.9% | |
| RAIN | RAIN THERAPEUTICS INC | $5,734,000 | -12.2% | 1,175,000 | 0.0% | 0.32% | -22.2% | |
| SELB | SELECTA BIOSCIENCES INC | $5,386,000 | +25.2% | 3,284,072 | 0.0% | 0.30% | +11.4% | |
| BCAB | BIOATLA INC | $5,285,000 | +170.2% | 686,347 | 0.0% | 0.30% | +139.5% | |
| THESEUS PHARMACEUTICALS INC | $5,174,000 | +4.9% | 892,057 | 0.0% | 0.29% | -6.7% | ||
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $5,030,000 | -17.4% | 1,251,137 | 0.0% | 0.28% | -26.7% | |
| BLSA | BCLS ACQUISITION CORP | $5,010,000 | +1.2% | 500,000 | 0.0% | 0.28% | -10.2% | |
| EQRX INC | $4,950,000 | +5.5% | 1,000,000 | 0.0% | 0.28% | -6.4% | ||
| PANA | PANACEA ACQUISITION CORP II | $4,900,000 | +0.4% | 500,000 | 0.0% | 0.28% | -10.7% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,960,000 | -0.6% | 400,000 | 0.0% | 0.22% | -11.5% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $3,778,000 | -30.6% | 2,134,598 | 0.0% | 0.21% | -38.6% | |
| BCEL | ATRECA INC | $3,458,000 | -12.3% | 2,202,333 | 0.0% | 0.19% | -22.4% | |
| BDTX | BLACK DIAMOND THERAPEUTICS I | $3,405,000 | -31.3% | 2,014,858 | 0.0% | 0.19% | -39.2% | |
| ORIC | ORIC PHARMACEUTICALS INC | $3,373,000 | -28.6% | 1,054,000 | 0.0% | 0.19% | -36.5% | |
| ZIOP | New | ALAUNOS THERAPEUTICS INC | $2,580,000 | – | 1,500,000 | +100.0% | 0.14% | – |
| GMTX | GEMINI THERAPEUTICS INC | $2,132,000 | -3.0% | 1,300,000 | 0.0% | 0.12% | -13.7% | |
| OMEG | OMEGA ALPHA SPACcl a | $1,986,000 | +0.8% | 200,000 | 0.0% | 0.11% | -10.4% | |
| MREO | MEREO BIOPHARMA GROUP PLCspon ads | $1,937,000 | -23.1% | 2,250,000 | 0.0% | 0.11% | -31.9% | |
| MEIP | MEI PHARMA INC | $1,126,000 | -36.1% | 2,913,091 | 0.0% | 0.06% | -43.8% | |
| TARA | PROTARA THERAPEUTICS INC | $619,000 | +1.0% | 209,227 | 0.0% | 0.04% | -10.3% | |
| CDAK | Sell | CODIAK BIOSCIENCES INC | $382,000 | -84.4% | 488,157 | -42.6% | 0.02% | -86.5% |
| CABA | CABALETTA BIO INC | $351,000 | -38.6% | 540,000 | 0.0% | 0.02% | -44.4% | |
| BELLICUM PHARMACEUTICALS INC | $68,000 | 0.0% | 56,950 | 0.0% | 0.00% | 0.0% | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $45,000 | -40.0% | 266,666 | 0.0% | 0.00% | -40.0% | |
| SURROZEN INC*w exp 08/01/203 | $11,000 | -15.4% | 66,666 | 0.0% | 0.00% | 0.0% | ||
| ELEV | Exit | Elevation Oncology Inc | $0 | – | -872,780 | -100.0% | -0.08% | – |
| ALGS | Exit | Aligos Therapeutics Inc | $0 | – | -1,526,048 | -100.0% | -0.12% | – |
| EPIX | Exit | Essa Pharma Inc | $0 | – | -724,500 | -100.0% | -0.14% | – |
| SLDB | Exit | Solid Biosciences Inc | $0 | – | -5,336,031 | -100.0% | -0.21% | – |
| GHRS | Exit | GH Research PLCordinary shares | $0 | – | -1,013,399 | -100.0% | -0.64% | – |
| NUVB | Exit | Nuvation Bio Inc | $0 | – | -4,341,009 | -100.0% | -0.89% | – |
| BMEA | Exit | Biomea Fusion Inc | $0 | – | -1,188,405 | -100.0% | -0.90% | – |
| XBI | Exit | SPDR SER TRs&p biotech | $0 | – | -500,000 | -100.0% | -2.35% | – |
| TPTX | Exit | Turning Point Therapeutics I | $0 | – | -570,745 | -100.0% | -2.72% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.